- New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B
-
Cho YK, Song BC
- KMID: 1128352
- Korean J Gastroenterol.
- 2011 Mar;57(3):144-149.
- doi: 10.4166/kjg.2011.57.3.144
Over the past decade, advances in the antiviral therapy in patients with chronic hepatitis B have enabled the sustained suppression of hepatitis B viral replication and the prevention of progressive... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
-
Kim YJ, Kim K, Hwang SH, Kim SS, Lee D, Cheong JY, Cho SW
- KMID: 1705208
- Clin Mol Hepatol.
- 2013 Sep;19(3):300-304.
- doi: 10.3350/cmh.2013.19.3.300
BACKGROUND/AIMS: Relapse has been reported after stopping nucleos(t)ide (NUC) therapy in the majority of chronic HBeAg negative hepatitis patients. However, the ideal treatment duration of HBeAg negative chronic hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
-
Jwa HY, Cho YK, Choi EK, Kim HU, Song HJ, Na SY, Boo SJ, Jeong SU, Kim BS, Lee BW, Song BC
- KMID: 2363038
- Clin Mol Hepatol.
- 2016 Mar;22(1):183-187.
- doi: 10.3350/cmh.2016.22.1.183
Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus
-
Lee HJ, Choi JW, Kim TN, Eun JR
- KMID: 1381468
- Korean J Hepatol.
- 2008 Sep;14(3):381-386.
- doi: 10.3350/kjhep.2008.14.3.381
Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus (HBV) replication but exhibits nephrotoxicity with severe hypophosphatemia when administered at a high dosage. This is the first report of severe hypophosphatemic... -
- CITED
-
- Close
- SHARE
-
- Close
- Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
-
Moon JC, Kim SH, Kim IH, Lee CH, Kim SW, Lee SO, Lee ST, Kim DG
- KMID: 2155648
- Gut Liver.
- 2015 May;9(3):395-404.
- doi: 10.5009/gnl14170
BACKGROUND/AIMS: We investigated factors associated with the disease progression and development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients during long-term oral nucleos(t)ide analog (NA) therapy. METHODS: This retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naive patients with chronic hepatitis B infection
-
Chung WG, Kim HJ, Choe YG, Seok HS, Chon CW, Cho YK, Kim BI, Koh YY
- KMID: 1743727
- Clin Mol Hepatol.
- 2012 Jun;18(2):195-202.
- doi: 10.3350/cmh.2012.18.2.195
BACKGROUND/AIMS: The aim of this study was to analyze the clinical impacts of obesity and hazardous alcohol use on the outcome of entecavir (ETV) therapy in chronic hepatitis B (CHB)... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
-
Shim JJ, Oh IH, Kim SB, Kim JW, Lee CK, Jang JY, Lee JS, Kim BH
- KMID: 2412103
- Gut Liver.
- 2016 Nov;10(6):962-968.
- doi: 10.5009/gnl15426
BACKGROUND/AIMS: The benefit of oral antiviral therapy in preventing hepatocellular carcinoma (HCC) in the general population is not well understood. We used a novel prediction method to estimate the risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
-
Lee S, Park JY, Song K, Kim DY, Kim BK, Kim SU, Ku HJ, Han KH, Ahn SH
- KMID: 2377936
- Gut Liver.
- 2015 Nov;9(6):776-783.
- doi: 10.5009/gnl14297
BACKGROUND/AIMS: The aim of this study was to evaluate the estimated glomerular filtration rate (eGFR) during telbivudine (LdT) versus entecavir (ETV) treatment in chronic hepatitis B (CHB) patients with underlying... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naive and nucleos(t)ide analogue-experienced chronic hepatitis B patients
-
Jung SK, Kim KA, Ha SY, Lee HK, Kim YD, Lee BH, Paik WH, Kim JW, Bae WK, Kim NH, Lee JS, Jwa YJ
- KMID: 2155290
- Clin Mol Hepatol.
- 2015 Mar;21(1):41-48.
- doi: 10.3350/cmh.2015.21.1.41
BACKGROUND/AIMS: This study investigated the antiviral effects of tenofovir disoproxil fumarate (TDF) monotherapy in nucleos(t)ide analogue (NA)-naive and NA-experienced chronic hepatitis B (CHB) patients. METHODS: CHB patients treated with TDF monotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naive chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
-
Ahn SS, Chon YE, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH, Park JY
- KMID: 2069762
- Clin Mol Hepatol.
- 2014 Sep;20(3):261-266.
- doi: 10.3350/cmh.2014.20.3.261
BACKGROUND/AIMS: This study assessed the antiviral efficacy and safety of tenofovir disoproxil fumarate (TDF) for up to 12 months in Korean treatment-naive chronic hepatitis B (CHB) patients. METHODS: A total of... -
- CITED
-
- Close
- SHARE
-
- Close
- Entecavir Therapy for Patients with Hepatitis B Virus-related Decompensated Cirrhosis
-
Kim IS, Mun JI, Koo JH, Kang CJ, Bak JK, Cheong JY, Cho SW
- KMID: 1245207
- Korean J Gastroenterol.
- 2012 Mar;59(3):224-231.
- doi: 10.4166/kjg.2012.59.3.224
BACKGROUND/AIMS: Entecavie (ETV) has a potent antiviral effect and low rates of resistance in hepatitis B virus (HBV) and is the first-line monotherapy in patients with HBV-related decompensated cirrhosis. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
-
Lee J, Yoo SH, Sohn W, Kim HW, Choi YS, Won JH, Heo JY, Park SJ, Park YM
- KMID: 2373134
- Clin Mol Hepatol.
- 2016 Sep;22(3):339-349.
- doi: 10.3350/cmh.2016.0021
BACKGROUND/AIMS: This study aimed to clarify the effect of obesity on the development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients receiving antiviral treatment. METHODS: This study applied a... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
-
Sohn W, Cho JY, Kim JH, Lee JI, Kim HJ, Woo MA, Jung SH, Paik YH
- KMID: 2413121
- Clin Mol Hepatol.
- 2017 Jun;23(2):170-178.
- doi: 10.3350/cmh.2016.0086
BACKGROUND/AIMS: This study aimed to develop and validate a risk prediction model for the development of hepatocellular carcinoma (HCC) in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
-
Chung GE, Cho EJ, Lee JH, Yoo JJ, Lee M, Cho Y, Lee DH, Kim HY, Yu SJ, Kim YJ, Yoon JH, Zoulim F
- KMID: 2412116
- Clin Mol Hepatol.
- 2017 Mar;23(1):66-73.
- doi: 10.3350/cmh.2016.0060
BACKGROUND/AIMS: A recent study reported that entecavir had inferior efficacy in nucleos(t)ide analogue (NA)-experienced chronic hepatitis B (CHB) patients compared to NA-naïve patients. We sought to compare the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
